Duality Advisers, LP Kodiak Sciences Inc. Transaction History

Duality Advisers, LP

  • $0
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 08, 2022
SELL
$5.04 - $9.48 $834,760 - $1.57 Million
-165,627 Closed
0 $0
Q1 2022

May 09, 2022
BUY
$7.09 - $89.45 $1.17 Million - $14.8 Million
165,627 New
165,627 $1.28 Million
Q3 2021

Nov 08, 2021
SELL
$81.97 - $106.94 $376,570 - $491,282
-4,594 Closed
0 $0
Q2 2021

Aug 09, 2021
BUY
$77.2 - $126.54 $354,656 - $581,324
4,594 New
4,594 $427,000

Others Institutions Holding KOD

# of Institutions
99
Shares Held
39M
Call Options Held
6.5K
Put Options Held
5.8K
View Full List

About Kodiak Sciences Inc.

KOD Quotes by TradingView
  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $475M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track This Portfolio

Track Duality Advisers, LP Portfolio

Follow Duality Advisers, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Duality Advisers, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email